Allstate Corp Makes New $1.30 Million Investment in Xylem Inc. $XYL

Allstate Corp acquired a new stake in Xylem Inc. (NYSE:XYL) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 8,789 shares of the industrial products company’s stock, valued at approximately $1,296,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. SJS Investment Consulting Inc. raised its holdings in Xylem by 1,844.4% in the third quarter. SJS Investment Consulting Inc. now owns 175 shares of the industrial products company’s stock valued at $26,000 after acquiring an additional 166 shares in the last quarter. First Horizon Corp acquired a new position in Xylem during the 3rd quarter worth approximately $30,000. Maseco LLP purchased a new stake in shares of Xylem in the 2nd quarter valued at approximately $31,000. ST Germain D J Co. Inc. raised its holdings in shares of Xylem by 950.0% in the 2nd quarter. ST Germain D J Co. Inc. now owns 252 shares of the industrial products company’s stock valued at $33,000 after purchasing an additional 228 shares in the last quarter. Finally, Signature Resources Capital Management LLC acquired a new stake in shares of Xylem in the 2nd quarter valued at $39,000. 87.96% of the stock is owned by institutional investors and hedge funds.

Xylem Stock Performance

NYSE XYL opened at $138.81 on Wednesday. The firm has a market cap of $33.80 billion, a P/E ratio of 35.68, a P/E/G ratio of 2.07 and a beta of 1.17. Xylem Inc. has a 52-week low of $100.47 and a 52-week high of $154.27. The business’s 50-day moving average price is $139.94 and its 200 day moving average price is $141.39. The company has a quick ratio of 1.50, a current ratio of 1.96 and a debt-to-equity ratio of 0.17.

Xylem (NYSE:XYL) last posted its quarterly earnings data on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share for the quarter, topping analysts’ consensus estimates of $1.23 by $0.14. The company had revenue of $2.27 billion during the quarter, compared to analysts’ expectations of $2.22 billion. Xylem had a return on equity of 10.77% and a net margin of 10.66%.The firm’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same period last year, the firm earned $1.11 EPS. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. On average, equities research analysts expect that Xylem Inc. will post 4.65 earnings per share for the current year.

Xylem Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 23rd. Shareholders of record on Tuesday, November 25th were given a dividend of $0.40 per share. The ex-dividend date was Tuesday, November 25th. This represents a $1.60 dividend on an annualized basis and a yield of 1.2%. Xylem’s dividend payout ratio is presently 41.13%.

Analyst Ratings Changes

A number of brokerages recently commented on XYL. Royal Bank Of Canada boosted their target price on shares of Xylem from $169.00 to $176.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 29th. Cowen reaffirmed a “hold” rating on shares of Xylem in a report on Friday, December 5th. Robert W. Baird set a $178.00 price objective on Xylem in a research report on Wednesday, October 29th. Citigroup increased their price objective on Xylem from $173.00 to $182.00 and gave the company a “buy” rating in a report on Wednesday, October 29th. Finally, Zacks Research cut Xylem from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 18th. Eight equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $165.80.

Insider Buying and Selling at Xylem

In related news, EVP Claudia S. Toussaint sold 10,421 shares of the stock in a transaction dated Thursday, October 30th. The shares were sold at an average price of $152.64, for a total transaction of $1,590,661.44. Following the completion of the transaction, the executive vice president directly owned 31,250 shares of the company’s stock, valued at $4,770,000. This represents a 25.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Victoria D. Harker sold 1,700 shares of Xylem stock in a transaction that occurred on Tuesday, November 4th. The shares were sold at an average price of $148.14, for a total value of $251,838.00. Following the completion of the sale, the director directly owned 16,875 shares in the company, valued at $2,499,862.50. This represents a 9.15% decrease in their position. The SEC filing for this sale provides additional information. 0.27% of the stock is currently owned by company insiders.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.